(Date:11/20/2009)...earchers report that a class of heart medications ...l, effect on the heart, depending on their molecul...ournal Circulation Research , found that beta-blo...rs on the heart muscle offer the most benefit to c...beta-receptors can actually undermine the structur...
(Date:11/19/2009)...evealing the genetic instructions inside corn, one...s one of the most complex sequences of DNA ever an...icist David Schwartz, who was one of more than 100..., "The maize genome is a true maze full of conf...ld-be sequencers for years," says Schwartz. , Pu...
(Date:11/19/2009)...sity in maize, also known as corn, researchers acr...hat should pave the way to significant improvement... animal feed and fiber around the world. , The n...otype map, charts genetic diversity and recombinat... The research team, led by U.S. Department of Agri...
Breaking Biology News(10 mins):Carvedilol shown to have unique characteristics among beta blockers 2Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3Substance Abuse Expert Dr Drew Joins Forces with the Five Moms to Raise Awareness About OTC Cough Medicine Abuse Among Teens 59825 1Substance Abuse Expert Dr Drew Joins Forces with the Five Moms to Raise Awareness About OTC Cough Medicine Abuse Among Teens 59825 2Substance Abuse Expert Dr Drew Joins Forces with the Five Moms to Raise Awareness About OTC Cough Medicine Abuse Among Teens 59825 3New Study Details Complex Health Care Needs of Medicaids Highest Need Highest Cost Populations 59821 1New Study Details Complex Health Care Needs of Medicaids Highest Need Highest Cost Populations 59821 2New Study Details Complex Health Care Needs of Medicaids Highest Need Highest Cost Populations 59821 3Celsis IVT Granted U S Patent for LiverPool 28TM 29 Hepatocytes 14543 1Celsis IVT Granted U S Patent for LiverPool 28TM 29 Hepatocytes 14543 2(Date:11/19/2009)...TLE, Nov. 19 Omeros Corp... financial results for the third quarter ended Sep...ber 30, 2009, Omeros reported a net loss of $3.9 m...oss of $7.4 million, or $2.54 per share, for the s...ember 30, 2009, the Company reported a net loss of...
(Date:11/19/2009)... ,, BETHESDA, Md., Nov. 19 /PRNewswire-FirstCa...nnovator in biotechnology for diabetes therapy, an...g services to food, supplement, biotechnology and ...d the previously reported $6.3 million registered ...60,870 shares of its common stock and warrants to ...
(Date:11/19/2009)...ESDA, Md., Nov. 19 Spher...biotechnology for diabetes therapy, and a provider...o food, supplement, biotechnology and pharmaceutic...ay,s Annual Meeting of Shareholders. ,, At the ...daq: SPEX ) elected the following members to the ...
(Date:11/19/2009)... MUNSTER, Germany, November 19 M...d on November 16th, 2009 Flibanserin in the,indica...a in Parkinson,s,disease for orphan drug status de...). Levodopa-induced dyskinesia is a complication o...nd a serious burden to some of those,affected, sin...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2... Training Physician for both Botox and Fraxel...st in Orange County begins in-office clinical proc...Botox as a pre-treatment to enhance the improvemen... this study will be resistant lip lines in women o...ge County, CA (PRWEB) January 1, 2009 -- To find a...
...lif., Jan. 2 Valeant,Pharmaceuticals Internationa...cember 31, 2008, the company completed its acquisi...tely held dermatology company that specializes in ...ry basis, as well as for,pharmaceutical and biotec...nt Pharmaceuticals International (NYSE: VRX ) is...
...if., Jan. 2 Bionovo, Inc.,(Nasdaq: BNVI ) annou...,regulatory elements that can be used to identify ...ed in Molecular and Cellular Endocrinology, showed...the estrogenic,pharmacological activity exerted by...rediction of specific tissue effect. , "Select...
Other Biology Technology:Irvine Dermatologist Begins In-office Clinical Studies -- Nissan Pilest, MD Combines Multi-Use Botox in Laser Resurfacing Clinical Studies 2Irvine Dermatologist Begins In-office Clinical Studies -- Nissan Pilest, MD Combines Multi-Use Botox in Laser Resurfacing Clinical Studies 3Bionovo Publishes Discoveries in Predictable Tissue Selectivity for Selective Estrogen Receptor Modulators Platform 2Bionovo Publishes Discoveries in Predictable Tissue Selectivity for Selective Estrogen Receptor Modulators Platform 3...the chance of error. Thats the safeguard built int...xtensive experience in laboratory automation and l... the CEQ 8000 is a fully automated genetic analysi...llary array with a patented linear polyacrylamide ...
...s a major advance in liquid dispensing technology ...liquid handlers into the realm of the small bencht...from 10mL to 2mL per well, the micro 10 has unique...sers. ,Features: , Never needs re-calibrat...
PerkinElmer Spectrum Beer's Law QUANT Quantitative Software, CD from PerkinElmer
Murashige and Skoog basal salt solution with Gamborg's B5 vitamins, 10X concentrate from Research Organics, Inc.
Biology Products: